Enlarge image
Hospital in Thuringia (archive image)
Photo: Bodo Schackow / dpa
The Robert Koch Institute (RKI) reports
107,568 new infections
within 24 hours.
That is 5,954 fewer cases than on Tuesday a week ago, when 113,522 corona infections were reported.
The nationwide
seven-day incidence
rises to
522.7
from 499.2 the previous day.
218 other people died
in connection with the virus.
This increases the number of reported deaths to 136,756.
A year and a half after the start of the first vaccinations, the corona vaccine market is about to change course.
At least in the industrialized nations, most people who wanted to be vaccinated against Covid-19 have now been vaccinated.
Around five billion worldwide.
For the vaccine manufacturers, who have been producing under high pressure in recent months, the market is becoming much more competitive and smaller.
In the future, the focus should be on booster vaccinations or vaccinations for smaller children for whom there is not yet a vaccine on the market.
Biotech analyst Hartaj Singh from Oppenheimer expects tough competition: "Companies will fight for price and market share, even for vaccines that are considered the best, such as Pfizer and Moderna."
The number of boosters required is open
However, it is still completely open how many booster vaccinations will ultimately be needed.
So far, a second booster vaccination is only recommended in some countries for people at risk of severe disease or in certain occupational groups.
Likewise, it's still uncertain whether manufacturers will sell adapted vaccines this fall and every one thereafter -- such as flu vaccine vendors -- and what impact that might have on demand.
Manufacturers such as the US pharmaceutical group Pfizer, which works with Mainz-based Biontech, and the US biotech group Moderna nevertheless assume that they will continue to play an important role in the vaccine market in the future - even if overall demand falls.
Adults who have not yet been vaccinated will probably not be vaccinated more than two years after the pandemic began, as Pfizer boss Albert Bourla said in a recent interview.
Rather, it is the "already vaccinated" who should ensure demand.
jok/Reuters
